非酒精性脂肪肝
内科学
内分泌学
脂肪变性
肝硬化
脂肪性肝炎
脂肪肝
纤维化
医学
生物
疾病
作者
Bart Staels,A. Rubenstrunk,Benoît Noël,Géraldine Rigou,Philippe Delataille,Lesley J. Millatt,Morgane Baron,Anthony Lucas,Anne Tailleux,Dean W. Hum,Vlad Ratziu,Bertrand Cariou,Rémy Hanf
出处
期刊:Hepatology
[Lippincott Williams & Wilkins]
日期:2013-05-22
卷期号:58 (6): 1941-1952
被引量:398
摘要
The dual PPAR-α/δ agonist, GFT505, is a promising liver-targeted drug for treatment of NAFLD/NASH. In animals, its protective effects are mediated by both PPAR-α-dependent and -independent mechanisms.
科研通智能强力驱动
Strongly Powered by AbleSci AI